These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6718653)

  • 81. The use of placebos in controlled trials.
    Phillips M
    Ann Intern Med; 1992 Feb; 116(3):265. PubMed ID: 1558563
    [No Abstract]   [Full Text] [Related]  

  • 82. Placebo controls.
    Vahrman J
    J R Soc Med; 1995 Oct; 88(10):603. PubMed ID: 8537955
    [No Abstract]   [Full Text] [Related]  

  • 83. Keep digging until we get the result we want?
    Berger VW
    Contemp Clin Trials; 2012 Jan; 33(1):12. PubMed ID: 22001359
    [No Abstract]   [Full Text] [Related]  

  • 84. Check list for assessment of controlled therapeutic trials.
    Wulff HR
    Acta Neurol Scand Suppl; 1975; 60():79-80. PubMed ID: 1103557
    [No Abstract]   [Full Text] [Related]  

  • 85. Trials and errors.
    Knipschild P
    BMJ; 1993 Jun; 306(6894):1706-7. PubMed ID: 8343624
    [No Abstract]   [Full Text] [Related]  

  • 86. Statistical ward rounds. 2.
    Mainland D
    Clin Pharmacol Ther; 1967; 8(2):346-55. PubMed ID: 5336565
    [No Abstract]   [Full Text] [Related]  

  • 87. Commentary. Closed designs for sequential clinical trials.
    Becktel JM
    Clin Pharmacol Ther; 1970; 11(6):781-8. PubMed ID: 4921291
    [No Abstract]   [Full Text] [Related]  

  • 88. Controlled trials: planned deception?
    Spodick DH
    Lancet; 1979 Apr; 1(8119):780. PubMed ID: 86019
    [No Abstract]   [Full Text] [Related]  

  • 89. Interaction between prognostic factors and treatment.
    Shuster J; van Eys J
    Control Clin Trials; 1983 Sep; 4(3):209-14. PubMed ID: 6641234
    [TBL] [Abstract][Full Text] [Related]  

  • 90. On assessing treatment over time.
    Kurtzke JF
    J Chronic Dis; 1986; 39(11):939-40. PubMed ID: 3793843
    [No Abstract]   [Full Text] [Related]  

  • 91. Controlled trials in single subjects.
    Senn S
    BMJ; 1991 Sep; 303(6804):716-7. PubMed ID: 1912926
    [No Abstract]   [Full Text] [Related]  

  • 92. The performance of the two-stage analysis of two-treatment, two-period crossover trials.
    Cleophas TJ
    Stat Med; 1991 Mar; 10(3):489-91. PubMed ID: 2028131
    [No Abstract]   [Full Text] [Related]  

  • 93. [Letter: Controlled experiments].
    Jorgensen F
    Ugeskr Laeger; 1973 Sep; 135(37):1996. PubMed ID: 4774006
    [No Abstract]   [Full Text] [Related]  

  • 94. Statistical ward rounds--15.
    Mainland D
    Clin Pharmacol Ther; 1969; 10(3):407-15. PubMed ID: 4894831
    [No Abstract]   [Full Text] [Related]  

  • 95. [Studies on the effectivness of orally dispensed 1- (3'-Hydroxyphenyl)-2-aminoethanol-hydrochlorid (Novadral)].
    Gersmeyer EF; Albrecht H
    Med Welt; 1966 Mar; 13():657-63. PubMed ID: 5340908
    [No Abstract]   [Full Text] [Related]  

  • 96. [Experimental studies].
    Salleras Sanmartí L
    Aten Primaria; 1989 Dec; 6(10):745-50. PubMed ID: 2518902
    [No Abstract]   [Full Text] [Related]  

  • 97. Patient bias, investigator bias and the double-masked procedure in clinical trials.
    Ederer F
    Am J Med; 1975 Mar; 58(3):295-9. PubMed ID: 1090156
    [No Abstract]   [Full Text] [Related]  

  • 98. One-sided or two-sided p values?
    Goodman S
    Control Clin Trials; 1988 Dec; 9(4):387-8. PubMed ID: 3203530
    [No Abstract]   [Full Text] [Related]  

  • 99. Methodology of drug and placebo comparisons.
    Kellett J; Potamianos G
    Br J Psychiatry; 1984 Apr; 144():441-2. PubMed ID: 6722408
    [No Abstract]   [Full Text] [Related]  

  • 100. The importance of placebo effects.
    Cleophas TJ
    JAMA; 1995 Jan; 273(4):283; author reply 284. PubMed ID: 7815648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.